New Research Explores the Link Between Sleep Apnea and Gout
Overview of Sleep Apnea and Gout
Recent studies have highlighted the connection between sleep apnea and gout, particularly beyond the initial year following a sleep apnea diagnosis. Historically, the relationship between these two conditions has not been extensively examined, even though both are associated with elevated uric acid levels. Gout is a painful inflammatory condition affecting the joints, caused by high uric acid, while sleep apnea has also been linked to increased uric acid levels.
Prevalence and Shared Risk Factors
In the United Kingdom, gout and sleep apnea exhibit similar prevalence rates and share common risk factors, including hypertension, cardiovascular disease, obesity, and diabetes. Despite these parallels, the implications of sleep apnea on the likelihood of developing gout have been largely overlooked in research.
Mechanism Linking Sleep Apnea to Increased Uric Acid Production
Effects of Sleep Apnea on the Body
Sleep apnea results in intermittent oxygen supply interruptions, which can lead to an accelerated turnover of nucleotides. This process generates purines, which are subsequently converted into uric acid. This mechanism likely explains the connection between sleep apnea and the increased risk of developing gout.
Previous Research Findings
A prior study indicated that individuals with sleep apnea had a 50% higher chance of developing gout within a year of diagnosis. However, the long-term effects of sleep apnea on gout risk remained unexplored until recently.
Longitudinal Study on Sleep Apnea and Gout Risk
Study Design and Population
Researchers from the United Kingdom conducted a retrospective cohort study to investigate the association between sleep apnea and gout over an extended follow-up period. The study utilized the Clinical Practice Research Datalink, a comprehensive database reflecting the general population in the UK. It involved patients aged 18 and older diagnosed with sleep apnea, matched with up to four individuals without the condition for comparison. Both groups shared similar characteristics, with the primary outcome being the time until the first gout diagnosis. The median follow-up duration was 5.8 years.
Findings on Gout Incidence
During the follow-up period, nearly 5% of patients with sleep apnea developed gout, compared to 2.6% of the control group. The incidence rate of gout per 1,000 person-years was 7.83 in the sleep apnea group versus 4.03 in the comparator group. The highest risk of gout was observed within the first one to two years post-diagnosis, although an elevated risk persisted throughout the entire follow-up period. The increased risk was evident across all BMI categories, with the greatest risk found among individuals with a normal BMI. Despite potential misclassification risks regarding diagnosis, researchers deemed this unlikely to influence the study’s results.
Implications for Treatment and Future Research
Potential Role of CPAP Therapy
Sleep apnea is commonly treated with continuous positive airways pressure (CPAP) therapy, which maintains stable oxygen levels. Theoretically, this treatment could help reduce uric acid production and subsequently lower the risk of gout. However, further studies are necessary to validate the effectiveness of CPAP in preventing or managing gout among sleep apnea patients.
Conclusion
This research underscores the importance of understanding the long-term implications of sleep apnea on gout risk. Continued investigation is essential to develop effective treatment strategies that address both conditions.
References
Blagojevic-Bucknall, M., Mallen, C., Muller, S., Hayward, R., West, S., Choi, H., & Roddy, E. (2018). The risk of gout among patients with sleep apnea: A matched cohort study. Arthritis & Rheumatology. doi:10.1002/art.40662
Peters, D. (2018, August 30). Obstructive Sleep Apnea Linked with Higher Risk of Gout. Retrieved from https://newsroom.wiley.com/press-release/arthritis-rheumatology/obstructive-sleep-apnea-linked-higher-risk-gout